BONE MARROW CHARACTERISTICS IN PATIENTS WITH PRIMARY MYELOFIBROSIS AT THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION

Ngọc Dũng Nguyễn1,, Hải Quân 1
1 Central Institute of Hematology and Blood Transfusion

Main Article Content

Abstract

Objectives: To study some characteristics of bone marrow in patients with primary myelofibrosis at the National Institute of Hematology and Blood Transfusion. Subjects and methods: We conducted a retrospective cross-sectional study on 43 patients diagnosed with primary myelofibrosis at the Department of General Blood Diseases, National Institute of Hematology and Blood Transfusion, from January 2017 to May 2022. Results: Most patients with primary myelofibrosis had poor marrow density, accounting for 65.1%. Bone marrow decreased erythrocyte production (69.8%), most of which had red blood cell line morphological disorders. 53.5% of patients had a decreased leukocyte lineage. Leukocyte morphology disorder accounted for 93%, mainly disorders in the intermediate stage of granulocytes. 100% of patients had fibroblast proliferation at different levels accompanied by morphological disorders of megakaryocyte (55.8% of megakaryocytes with large size, large shaggy nuclei with reduced abs; bare megakaryocytes nuclei accounted for 9.3%), megakaryocytes standing in groups accounted for 69.8%.

Article Details

References

1. Dameshek W. Some speculations on the myeloproliferative syndromes, Blood, 1951; 6, 372.
2. Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood,2016;127(20):2391-2405.
3. Teffri A. Myelofibrosis with myeloid metaplasia. New England Jounrnal of Medicine, 2000;342:1255-65.
4. Dương Thị Thuỳ Linh. Đặc điểm mô bệnh học và mức độ xơ ở một số bệnh tăng sinh tuỷ mạn ác tính tại bệnh viện Bạch Mai. Luận văn chuyên khoa cấp II; 2021
5. Vũ Đức Bình. Nghiên cứu đặc điểm lâm sàng và xét nghiệm bệnh xơ tuỷ nguyên phát tại Viện Huyết học - Truyền máu TW giai đoạn 2015-2017, Tổng hội Y Học Việt Nam; BV1; Tập 466; Số đặc biệt; Tháng 5/2018 – 932-939
6. Nazha A, Estrov Z, Cortes J, Bueso-Ramos CE, Kantarjian H, Verstovsek S. Prognostic implications and clinical characteristics associated with bone marrow fibrosis in patients with myelofibrosis. Leuk Lymphoma. 2013; 54(11):2537-2539.
7. Olga Pozdnyakova, Kaida Wu, Abhay Patki. High concordance in grading reticulin fibrosis and cellularity in patients with myeloproliferative neoplasms. Modern pathology,2014;27,1447-1454.
8. Umberto Gianelli, et al. The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol, 2012;25(9):1193:202.